0001127602-21-013551.txt : 20210409 0001127602-21-013551.hdr.sgml : 20210409 20210409160432 ACCESSION NUMBER: 0001127602-21-013551 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210330 FILED AS OF DATE: 20210409 DATE AS OF CHANGE: 20210409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeLong Mark Jeffrey CENTRAL INDEX KEY: 0001856078 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 21817837 MAIL ADDRESS: STREET 1: 100 5TH AVENUE, 3RD FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2021-03-30 0 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001856078 DeLong Mark Jeffrey C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Senior Vice President Common Stock 8698 D Stock Option (Right to Buy) 44.90 2031-01-27 Common Stock 30000 D Stock Option (Right to Buy) 44.33 2030-02-09 Common Stock 18750 D Stock Option (Right to Buy) 15.52 2028-02-04 Common Stock 50000 D Stock Option (Right to Buy) 13.85 2029-02-27 Common Stock 30000 D This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant date, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service. /s/ David Watson, attorney-in-fact for Mark Delong 2021-04-09 EX-24 2 doc1.txt POWER OF ATTORNEY (PUBLIC): POA Know all by these presents, that the undersigned hereby makes, constitutes and appoints each of David O. Watson and Timothy Sullivan, signing singly and each acting individually, as the undersigneds true and lawful attorneyinfact with full power and authority as hereinafter described to 1 execute for and on behalf of the undersigned, in the undersigneds capacity as officer of Apellis Pharmaceuticals, Inc. the Company, Forms?3, 4, and 5 including any amendments thereto in accordance with Section?16a of the Securities Exchange Act of 1934, as amended, and the rules thereunder the Exchange Act 2 do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to prepare, complete and execute any such Form?3, 4, or 5, prepare, complete and execute any amendment or amendments thereto, and timely deliver and file such form with the United States Securities and Exchange Commission the SEC and any stock exchange or similar authority, including without limitation the filing of a Form ID, Update Passphrase, or any other application materials to enable the undersigned to gain or maintain access to the Electronic Data Gathering, Analysis and Retrieval system of the SEC 3 seek or obtain, as the undersigneds representative and on the undersigneds behalf, information regarding transactions in the Companys securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to such attorneyinfact and approves and ratifies any such release of information and 4 take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorneyinfact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorneyinfact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorneyinfact may approve in suchattorneyinfact discretion. The undersigned hereby grants to each such attorneyinfact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneyinfact, or such attorneyinfact substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneyinfact, in serving in such capacity at the request of the undersigned, are not assuming nor relieving, nor is the Company assuming nor relieving, any of the undersigneds responsibilities to comply with Section?16 of the Exchange Act. The undersigned acknowledges that neither the Company nor the foregoing attorneyinfact assume i any liability for the undersigneds responsibility to comply with the requirements of the Exchange Act, ii any liability of the undersigned for any failure to comply with such requirements, or iii any obligation or liability of the undersigned for profit disgorgement under Section 16b of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms?3, 4, and 5 with respect to the undersigneds holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneyinfact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 31st day of March, 2021. Mark DeLong Name Mark DeLong LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS DC 573852 1301253 v1 ActiveUS 186209981v 1